Contrive Datum Insights values the global tissue banking equipment market at USD 2.4 billion in 2025 and projects it to reach USD 2.65 billion in 2026 and USD 5.72 billion by 2034, a compound annual growth rate of 10.1% over the forecast period. The finding appears in the firm's report, "Tissue Banking Equipment Market Size, Share & Industry Analysis, By Type (Freezers, Storage System, Thawing Equipment, Labelling and Coding Equipment, Other), Application (Tissue Banks, Hospitals, Research and Academics Institutes, Diagnostic Laboratories, Other), Tissue Type (Musculoskeletal Tissue, Ocular Tissue, Skin Tissue, Cardiovascular Tissue, Reproductive Tissue and Other), Technology (Cryopreservation, Controlled-Rate Freezing, Refrigerated/Non-Freezing Storage, Vitrification), Automation Level (Manual Systems, Semi-Automated Systems, Automated Systems), and Regional Forecast, 2026-2034."
The market covers the equipment that keeps donated human tissue viable and traceable between recovery and clinical use: ultra-low-temperature and liquid-nitrogen freezers, controlled-rate freezing chambers, vitrification units, thawing equipment, and the barcode- and RFID-based labelling and racking hardware that lets a bank track an item from bone or skin grafts through to corneas and heart valves. Buyers include accredited tissue banks, hospital transplant services, and the research institutes and diagnostic laboratories that handle donated tissue under comparable chain-of-custody rules.
Cell and gene therapy capacity expansion is the factor the report rates as the largest single contributor to growth through 2034, with high impact. As more therapy developers need cryogenic storage on short notice, tissue banks are adding capacity faster than the market average: the "Other" type category, which captures this demand, grows at 10.77% a year, taking its revenue from USD 0.14 billion to USD 0.34 billion.
That growth sits next to a much larger, steadier base. Freezers remain the largest type line throughout the forecast, worth USD 0.91 billion in 2025. Storage systems grow more slowly, at 9.72% a year. Elsewhere in the segmentation, Tissue Banks lead application demand at USD 0.84 billion in 2025 while Research and Academic Institutes grow fastest, at 11.41%; Musculoskeletal Tissue leads the tissue-type split at USD 0.77 billion while Cardiovascular Tissue grows fastest, at 11.11%; Cryopreservation leads by technology at USD 1.08 billion while Vitrification grows fastest, at 12.45%; and Manual Systems lead by automation level at USD 0.96 billion while Automated Systems grow fastest, at 13.52%.
Geographically, North America holds the largest share of 2025 revenue at USD 0.96 billion and is projected to reach USD 2.06 billion by 2034. Within that, the United States alone accounts for USD 0.84 billion, 35% of global 2025 revenue, making it the single largest country market tracked in the study. Middle East and Africa stays the smallest region across the full forecast window.
The 10.1% base case sits between two scenarios the report also models. If hospital and regional tissue banks delay planned freezer and automation purchases on tight capital budgets, 2034 revenue comes in closer to USD 5.15 billion. If clinical adoption of cell and gene therapy accelerates faster than assumed and banks expand cryogenic capacity sooner, 2034 revenue can instead reach USD 6.29 billion. The full report covers all five regions with country-level detail, segment-by-segment revenue from 2020 through 2034, and the methodology behind each estimate; it is delivered as a PDF, and a free sample is available on request.